On 21 May 2026, the Medicines and Healthcare products Regulatory Agency (“MHRA”) published its draft regulatory framework for rare...
On 15 April 2026, the European Data Protection Board (the "EDPB") adopted draft Guidelines 1/2026 on processing of personal data for...
In January 2026, the FDA and the European Medicines Agency (the “EMA”) published a set of guiding principles for the use of AI across the...